Covering Cutting-Edge Scientific and Business Trends in Drug Delivery
Pharma, biotech and drug delivery industries will gather at the 15th annual PODD event to assess delivery needs, explore partnership opportunities, and stay at the forefront of innovative drug delivery technologies. This includes small molecules, biologics, combination products, connected devices, cell and gene delivery and more.
On October 27th, 3:30 – 3:45 PM, our expert Eunice Costa (R&D Program Director) will lead the Session:
Novel Synthetic Sugar Excipients for Proteins: Reducing Viscosity and Ensuring Stability
Biopharmaceuticals are a growing segment in Pharma with still significant formulation challenges like viscosity of high concentration forms, and stability. Traditional excipients often fall short, driving the need for next-generation solutions. Hovione will be presenting a library of novel synthetic sugars that have enabled notable improvements in viscosity reduction and stability, putting forward a rational approach towards finding the best excipient-protein combination.
Join the session to gain insight about:
- Introduction to novel nature-inspired sugar excipients: leveraging from mechanisms found in nature to address challenges in Biologics processing & drug product.
- Next-generation excipients in action: case-studies addressing viscosity reduction of high-concentration monoclonal antibodies for subcutaneous administration while ensuring stability
- Rational formulation design approach: leveraging on mechanistic understanding, modeling and screening for fine-tuning the excipient composition to the specific molecule and application
Do you want to know how Hovione can support your project? Schedule a meeting today.
